1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Song, J. Laskowski Jr., M. Qasim, M.A. Markley, J.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 42 6380 6391 10.1021/bi034053f 12767219 Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics. 2003 10.2210/pdb1m8c/pdb pdb_00001m8c 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 6044.783 Ovomucoid RESIDUES 130-185; KAZAL-LIKE 3 (INHIBIT CHYMOTRYPIN, ELASTASE, ETC.) P14D 1 syn polymer no no LAAVSVDCSEYPKDACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC LAAVSVDCSEYPKDACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-09-04 1 1 2008-04-28 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details SOLUTION STRUCTURE OF THE C State OF TURKEY OVOMUCOID AT PH 2.5 RCSB Y RCSB 2002-07-24 REL The sequence for Ovomucoid fragment was chemically synthesized. It occurs naturally in Meleagris gallopavo (Common turkey). sample structures with favorable non-bond energy 50 20 3D_13C-separated_NOESY 3D_15N-separated_NOESY 2D NOESY 2D NOESY no salt added 2.5 ambient 298 K torsion angle dynamics, simulated annealing 1 lowest energy 1 mM 90% H2O/10% D2O 1 mM 100% D2O collection XwinNMR 3.2 processing Felix 95 data analysis Sparky 3.72 structure solution DYANA 1.5 refinement DYANA 1.5 750 Bruker DMX 600 Bruker AMX 500 Bruker DMX LEU 1 n 1 LEU 1 A ALA 2 n 2 ALA 2 A ALA 3 n 3 ALA 3 A VAL 4 n 4 VAL 4 A SER 5 n 5 SER 5 A VAL 6 n 6 VAL 6 A ASP 7 n 7 ASP 7 A CYS 8 n 8 CYS 8 A SER 9 n 9 SER 9 A GLU 10 n 10 GLU 10 A TYR 11 n 11 TYR 11 A PRO 12 n 12 PRO 12 A LYS 13 n 13 LYS 13 A ASP 14 n 14 ASP 14 A ALA 15 n 15 ALA 15 A CYS 16 n 16 CYS 16 A THR 17 n 17 THR 17 A LEU 18 n 18 LEU 18 A GLU 19 n 19 GLU 19 A TYR 20 n 20 TYR 20 A ARG 21 n 21 ARG 21 A PRO 22 n 22 PRO 22 A LEU 23 n 23 LEU 23 A CYS 24 n 24 CYS 24 A GLY 25 n 25 GLY 25 A SER 26 n 26 SER 26 A ASP 27 n 27 ASP 27 A ASN 28 n 28 ASN 28 A LYS 29 n 29 LYS 29 A THR 30 n 30 THR 30 A TYR 31 n 31 TYR 31 A GLY 32 n 32 GLY 32 A ASN 33 n 33 ASN 33 A LYS 34 n 34 LYS 34 A CYS 35 n 35 CYS 35 A ASN 36 n 36 ASN 36 A PHE 37 n 37 PHE 37 A CYS 38 n 38 CYS 38 A ASN 39 n 39 ASN 39 A ALA 40 n 40 ALA 40 A VAL 41 n 41 VAL 41 A VAL 42 n 42 VAL 42 A GLU 43 n 43 GLU 43 A SER 44 n 44 SER 44 A ASN 45 n 45 ASN 45 A GLY 46 n 46 GLY 46 A THR 47 n 47 THR 47 A LEU 48 n 48 LEU 48 A THR 49 n 49 THR 49 A LEU 50 n 50 LEU 50 A SER 51 n 51 SER 51 A HIS 52 n 52 HIS 52 A PHE 53 n 53 PHE 53 A GLY 54 n 54 GLY 54 A LYS 55 n 55 LYS 55 A CYS 56 n 56 CYS 56 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A O TYR 31 A O TYR 31 A N LEU 23 A N LEU 23 A N CYS 24 A N CYS 24 A O HIS 52 A O HIS 52 3 A A O H GLY ASN 25 28 1.55 3 A A O H PRO ALA 12 15 1.59 4 A A O HG VAL SER 41 44 1.57 7 A A O H GLY ASN 25 28 1.57 10 A A O H GLY ASN 25 28 1.57 11 A A O HG1 SER THR 44 47 1.39 14 A A O H GLY ASN 25 28 1.57 14 A A OD1 HG ASP SER 7 9 1.59 1 A ALA 3 -174.23 121.66 1 A THR 17 -133.44 -137.46 1 A GLU 19 -66.91 99.36 1 A ASN 28 82.74 35.09 1 A ASN 45 89.04 3.93 2 A ALA 2 41.04 79.81 2 A ALA 15 -164.03 103.40 2 A CYS 16 168.58 63.53 2 A LEU 18 82.04 -55.70 2 A ASN 28 82.54 31.97 2 A HIS 52 -175.95 -177.49 3 A ALA 3 -68.38 75.73 3 A VAL 4 -49.78 166.01 3 A TYR 11 -157.24 67.24 3 A CYS 16 -174.76 87.16 3 A THR 17 -62.05 -129.45 3 A ASN 28 83.71 27.21 4 A ALA 2 61.14 89.39 4 A ALA 15 -109.93 63.25 4 A CYS 16 -175.65 105.72 4 A THR 17 -133.42 -130.91 4 A LEU 18 -39.43 -36.91 4 A GLU 19 -65.92 95.98 4 A HIS 52 -176.37 -179.98 5 A ALA 2 40.65 77.20 5 A SER 5 -175.11 141.24 5 A ALA 15 -163.00 101.56 5 A CYS 16 170.36 42.86 5 A LEU 18 84.62 -50.09 5 A ASN 28 81.39 27.13 6 A SER 5 63.09 125.01 6 A CYS 8 -92.11 40.53 6 A TYR 11 -175.02 80.19 6 A CYS 16 -174.09 61.17 6 A LEU 18 80.13 -54.28 6 A LEU 48 -39.92 145.09 6 A HIS 52 -175.71 -179.24 7 A ALA 2 -55.93 -171.99 7 A SER 5 -172.40 131.60 7 A CYS 8 -101.48 43.52 7 A TYR 11 -154.11 76.72 7 A ALA 15 -145.18 58.32 7 A CYS 16 -151.80 -105.32 7 A THR 17 52.58 172.79 7 A LEU 18 69.99 -61.89 7 A THR 49 -124.40 -168.91 8 A ALA 2 59.61 71.18 8 A SER 5 64.31 116.31 8 A THR 17 -64.29 -149.95 8 A ASN 28 84.01 37.85 8 A HIS 52 -175.03 -177.18 9 A TYR 11 179.82 88.83 9 A ALA 15 -88.73 -122.82 9 A CYS 16 41.42 74.67 9 A LEU 18 77.36 -59.68 9 A ASN 45 80.07 11.84 9 A LEU 48 -39.05 154.69 10 A ALA 3 65.76 116.08 10 A SER 5 66.32 118.51 10 A TYR 11 -168.48 88.26 10 A ALA 15 -108.65 -81.67 10 A CYS 16 45.75 26.77 10 A THR 17 36.79 -151.12 10 A ASN 28 81.56 30.47 10 A LEU 48 -37.56 145.42 11 A ALA 2 -103.87 76.89 11 A TYR 11 -165.19 91.38 11 A ALA 15 -79.49 -101.33 11 A CYS 16 42.14 85.07 11 A THR 17 -66.88 -140.13 11 A ASN 28 72.11 30.60 11 A LEU 48 -38.89 147.79 12 A ALA 2 45.88 -162.93 12 A ALA 3 67.88 82.76 12 A VAL 4 55.99 163.43 12 A SER 5 -179.68 123.93 12 A TYR 11 -175.93 73.69 12 A ALA 15 -172.80 74.54 12 A CYS 16 -179.15 59.10 12 A LEU 18 84.81 -55.04 12 A GLU 19 -66.35 99.87 12 A ASN 28 81.92 26.36 12 A THR 49 -119.58 -167.47 12 A LYS 55 -49.86 171.30 13 A TYR 11 -160.43 91.97 13 A CYS 16 -164.63 99.26 13 A THR 17 -131.51 -131.06 13 A LEU 18 -39.85 -29.84 13 A GLU 19 -65.22 97.79 13 A ASN 28 81.73 30.22 13 A LEU 48 -39.09 141.02 14 A ALA 2 -44.27 163.86 14 A ALA 3 67.47 160.85 14 A SER 5 -169.78 110.84 14 A TYR 11 -159.02 79.21 14 A ALA 15 -117.34 -125.74 14 A CYS 16 57.29 103.90 14 A THR 17 -67.69 -139.02 14 A GLU 19 -69.07 96.07 14 A LYS 55 -42.69 160.63 15 A ALA 2 -140.36 55.75 15 A SER 5 179.40 165.22 15 A TYR 11 -171.72 87.65 15 A ALA 15 -101.82 -123.85 15 A CYS 16 55.91 102.22 15 A THR 17 -61.26 -139.86 15 A ASN 28 83.18 36.09 15 A LEU 48 -39.31 144.42 15 A LYS 55 -43.17 158.90 16 A VAL 4 57.78 163.65 16 A SER 5 178.21 131.47 16 A TYR 11 -150.75 89.13 16 A THR 17 -117.82 -126.52 16 A LEU 18 -39.80 -29.30 16 A GLU 19 -64.82 96.04 16 A ASN 28 82.89 37.09 16 A LEU 48 -39.90 136.40 16 A LYS 55 -41.52 153.61 17 A ALA 3 -103.65 69.62 17 A SER 5 -179.64 135.91 17 A TYR 11 -167.16 86.02 17 A CYS 16 174.65 109.20 17 A THR 17 -133.23 -126.38 17 A LEU 18 -39.44 -34.68 17 A ASN 28 72.85 35.50 17 A HIS 52 -173.67 -175.71 18 A ALA 2 173.24 50.98 18 A ALA 3 175.07 178.77 18 A CYS 16 178.17 113.11 18 A THR 17 -138.08 -139.75 18 A ASN 28 73.79 40.74 18 A HIS 52 -176.01 -176.21 19 A VAL 4 58.15 164.78 19 A CYS 16 -167.26 105.54 19 A THR 17 -131.09 -133.44 19 A GLU 19 -65.68 97.60 19 A ASN 28 83.94 43.22 19 A LEU 48 -38.86 136.56 20 A ALA 3 -169.33 67.65 20 A TYR 11 -170.52 88.10 20 A CYS 16 177.01 105.92 20 A THR 17 -138.82 -119.83 20 A LEU 18 -39.21 -36.27 20 A ASN 28 78.72 33.44 20 A LEU 48 -39.87 150.63 20 A THR 49 -126.49 -169.00 SOLUTION STRUCTURE OF THE T State OF TURKEY OVOMUCOID AT PH 2.5 1 N N A ASN 33 A ASN 33 HELX_P A SER 44 A SER 44 1 1 12 disulf 2.099 A CYS 8 A SG CYS 8 1_555 A CYS 38 A SG CYS 38 1_555 disulf 2.036 A CYS 16 A SG CYS 16 1_555 A CYS 35 A SG CYS 35 1_555 disulf 2.097 A CYS 24 A SG CYS 24 1_555 A CYS 56 A SG CYS 56 1_555 HYDROLASE INHIBITOR OMTKY3 CONFORMATIONAL TRANSITION T STATE, CIS-TRANS ISOMERIZATION, HYDROLASE INHIBITOR IOVO_MELGA UNP 1 130 P01004 LAAVSVDCSEYPKPACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC 130 185 1M8C 1 56 P01004 A 1 1 56 1 PRO engineered mutation ASP 14 1M8C A P01004 UNP 143 14 3 anti-parallel anti-parallel A THR 30 A THR 30 A TYR 31 A TYR 31 A LEU 23 A LEU 23 A GLY 25 A GLY 25 A LEU 50 A LEU 50 A PHE 53 A PHE 53 1 P 1